Stryker (NYSE:SYK – Get Free Report) had its price objective lifted by BTIG Research from $374.00 to $383.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the medical technology company’s stock. BTIG Research’s price objective indicates a potential upside of 6.63% from the company’s current price. […]

MarketAxess Holdings Inc. (NASDAQ:MKTX – Get Free Report) has received a consensus recommendation of “Hold” from the eleven ratings firms that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and three have issued a buy recommendation on the company. The […]

Shares of Ferguson plc (NASDAQ:FERG – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine analysts that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the […]

Shares of DraftKings Inc. (NASDAQ:DKNG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-seven ratings firms that are covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The average twelve-month price […]

Raymond James reissued their outperform rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a research note issued to investors on Thursday, MarketBeat reports. Raymond James currently has a $36.00 target price on the stock. Several other research firms also recently weighed in on IMVT. JPMorgan Chase & Co. decreased their price objective on […]

Raymond James restated their strong-buy rating on shares of argenx (NASDAQ:ARGX – Free Report) in a research note released on Thursday, MarketBeat.com reports. The firm currently has a $605.00 price target on the stock. Other analysts also recently issued research reports about the company. Guggenheim restated a buy rating and issued a $585.00 price target […]

Shares of Xometry, Inc. (NASDAQ:XMTR – Get Free Report) have received a consensus rating of “Hold” from the seven analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating on […]

Raymond James reissued their market perform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note released on Thursday, MarketBeat reports. A number of other equities research analysts also recently commented on BIIB. Needham & Company LLC restated a buy rating and issued a $285.00 price objective on shares of Biogen in […]

Stephens reiterated their overweight rating on shares of 10x Genomics (NASDAQ:TXG – Free Report) in a report released on Thursday, Benzinga reports. Stephens currently has a $30.00 price objective on the stock. TXG has been the subject of several other reports. Leerink Partners initiated coverage on 10x Genomics in a research report on Tuesday, September […]

StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday. Several other equities research analysts have also commented on AMPH. Needham & Company LLC restated a hold rating on shares of Amphastar Pharmaceuticals in a research note on […]

Raymond James reaffirmed their market perform rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note released on Thursday morning, Marketbeat reports. Several other research analysts have also recently weighed in on the company. Robert W. Baird lowered their target price on Biogen from $316.00 to $294.00 and set an outperform rating […]

Shares of Cencora, Inc. (NYSE:COR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the ten brokerages that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price […]

Fiera Capital Co. (TSE:FSZ – Get Free Report) has received an average rating of “N/A” from the zero analysts that are currently covering the company, MarketBeat.com reports. A number of equities research analysts have recently commented on FSZ shares. TD Securities reduced their target price on shares of Fiera Capital from C$8.00 to C$7.50 in […]

Raymond James reaffirmed their outperform rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a research note published on Thursday, Marketbeat.com reports. The firm currently has a $36.00 price target on the stock. IMVT has been the subject of several other reports. UBS Group lowered their price target on Immunovant from $42.00 to $41.00 […]

Merck & Co., Inc. (NYSE:MRK – Free Report) had its price objective cut by Truist Financial from $143.00 to $132.00 in a research report report published on Wednesday, Benzinga reports. They currently have a buy rating on the stock. MRK has been the subject of several other reports. Bank of America decreased their price target […]

HC Wainwright reaffirmed their buy rating on shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) in a report released on Wednesday morning, Benzinga reports. HC Wainwright currently has a $90.00 price target on the biotechnology company’s stock. Several other equities research analysts also recently commented on VKTX. JPMorgan Chase & Co. initiated coverage on Viking […]